Metro Anti-cholesterol drug Praluent lowers risk of death, heart attack – Punch Newspapers

M

mrsam

Guest
The anti-cholesterol drug Praluent (alirocumab), made by France’s Sanofi Pharmaceuticals, is linked to a 15 percent lower risk of major cardiovascular events like heart attack and stroke, a study said Saturday. Alirocumab was also associated with a 15 percent reduction in death from any cause, marking the first …
Screenshot (39).png
Read more via Punch Newspapers – http://ift.tt/2FEaLoC
Get More Nigeria Metro News
 
Last edited by a moderator:
Top